Argus Research analyst Joseph Bonner downgrades Charter Communications (NASDAQ:CHTR) from Buy to Hold.
Where CymaBay Therapeutics Stands With Analysts
Over the past 3 months, 14 analysts have published their opinion on CymaBay Therapeutics (NASDAQ:CBAY) stock. These analysts…